Sodium hydroxide enhances the efficacy of rapamycin to suppress proliferation of Tsc2-null mouse embryonic fibroblasts

Abstract

Abstract: Objective To explore the effect of sodium hydroxide(NaOH) and rapamycin(Rapa) alone or their combination in treating Tsc2-null(Tsc2^-/-) mouse embryonic fibroblasts. Methods The wild type and Tsc2^-/- cells were treated with NaOH and/or Rapa and divided into 4 groups: control, NaOH group, Rapa group, and combination (Combo) group. Cell proliferation was measured by MTT assay and colony formation. Flow cytometry was used to detect the potential influence on cell cycle. The protein expression of S6, p-S6, p-4EBP1 was detected by Western blot. Results Compared to control group, Tsc2^-/- cells in NaOH and Rapa groups both showed a reduced proliferation ability and colony counting (P＜0.05); additionally, only in Rapa group, the percentage of Tsc2^-/- cells in G1 phase increased and the protein level of p-S6 and p-4EBP1 all decreased (P＜0.05). Compared with NaOH and Rapa groups, Tsc2^-/- cells in Combo group had a further decreased in proliferation ability and colony number and an increased G1 phase percentage (P＜0.05). But the level of p-S6 and p-4EBP1 of Tsc2^-/- cells in Combo group was significantly lower than those in NaOH group (P＜0.05). Conclusions NaoH(15 μmol/L) enhances the suppressing poliferation efficacy of Rapa in Tsc2^-/- cells.

Key words: tuberous sclerosis complex, mTOR, tumor microenvironment, rapamycin

CLC Number:

R737.11

LI Kai, WANG Ya-nan. Sodium hydroxide enhances the efficacy of rapamycin to suppress proliferation of Tsc2-null mouse embryonic fibroblasts[J]. Basic & Clinical Medicine, 2021, 41(7): 951-956.

References

[1]Henske EP, Jozwiak S, Kingswood JC, et al. Tuberous sclerosis complex[J/OL].Nat Rev Dis Primers, 2016, 2: 16035.doi: 10.1038/nrdp.2016.35
[2]Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 169: 361-371.
[3]Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond[J]. Cell, 2008, 134: 703-707.
[4]Sun Q, Chen X, Ma J, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth[J]. Proc Natl Acad Sci U S A, 2011, 108: 4129-4134.
[5]Webb BA, Chimenti M, Jacobson MP, et al. Dysre-gulated pH: a perfect storm for cancer progression[J]. Nat Rev Cancer, 2011, 11: 671-677.
[6]Wojtkowiak JW, Verduzco D, Schramm KJ, et al. Drug resistance and cellular adaptation to tumor acidic pH microenvironment[J]. Mol Pharm, 2011, 8: 2032-2038.
[7]Silva AS, Yunes JA, Gillies RJ, et al. The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion[J]. Cancer Res, 2009, 69: 2677-2684.
[8]Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, et al. Neutralization of tumor acidity improves antitumor res-ponses to immunotherapy[J]. Cancer Res, 2016, 76: 1381-1390.
[9]Zhang H, Bajraszewski N, Wu E, et al. Pdgfrs are critical for pi3k/akt activation and negatively regulated by mtor[J]. J Clin Invest, 2007, 117: 730-738.
[10]Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial[J]. Lancet, 2013, 381: 817-824.
[11]French JA, Lawson JA, Yapici Z, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study[J]. Lancet, 2016, 388: 2153-2163.
[12]Fingar DC, Richardson CJ, Tee AR, et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E[J]. Mol Cell Biol, 2004, 24: 200-216.

[1]	LIU Baoqing, HUANG Rong, LU Yan, LI Kai, ZHANG Ning, LIU Changzheng, SONG Wei. Progress of gastric cancer organoids in basic research and clinical application [J]. Basic & Clinical Medicine, 2024, 44(9): 1219-1222.
[2]	YAO Anjun, CHEN Lingzi, JIN Huixian. Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29 [J]. Basic & Clinical Medicine, 2024, 44(8): 1107-1112.
[3]	LI Yang, ZHU Lei. Eukaryotic elongation factor 2 kinase is a potential new target for the treatment of tumors [J]. Basic & Clinical Medicine, 2024, 44(7): 1039-1043.
[4]	LIU Siyi, YANG Yujiao, YANG Tao, ZHAO Xiuli. Identification of the causative variants in five Chinese families with tuberous sclerosis complex [J]. Basic & Clinical Medicine, 2024, 44(3): 361-367.
[5]	. Diagnosis and treatment of tuberous sclerosis complex with TSC2 mosaic mutation and multiple angiomyolipomas:a case report [J]. Basic & Clinical Medicine, 2024, 44(10): 1357-1362.
[6]	LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan. Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice [J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
[7]	ZHANG Hailing, YANG Yu, ZHOU Qianqian, WANG Yuanjin, WANG Ting. Neutrophil NETs treated with microcystin-LR promote migration of colorectal cancer cell [J]. Basic & Clinical Medicine, 2023, 43(6): 967-973.
[8]	LIU Zhan'ao, CHEN Chen. In vitro follicle activation as a strategy for assisted reproduction in patients with premature ovarian insufficiency: research advances [J]. Basic & Clinical Medicine, 2023, 43(4): 538-546.
[9]	LIU Tingting, HAN Chao, ZHAO Xiaoling, KONG Weimin. Metformin inhibits proliferation and promotes apoptosis of human cervical squamous cell carcinoma cell lines SiHa and CaSki [J]. Basic & Clinical Medicine, 2023, 43(2): 283-288.
[10]	XU Jiawen, TU Xinru, LIU Rui, JIANG Rui, TAO Long, YAO Yuyou. Learning and memory impairment of aged female mice induced by chronic stress [J]. Basic & Clinical Medicine, 2023, 43(2): 225-232.
[11]	JIA Nan, WANG Zhilian. CALCOCO1 in the progression of malignant tumors [J]. Basic & Clinical Medicine, 2023, 43(11): 1733-1737.
[12]	WANG Ping, XU Zuo-jun, XU Kai-feng. Tuberous sclerosis complex as a rare cause of multiple nodular and cystic lung disease:a case report [J]. Basic & Clinical Medicine, 2022, 42(9): 1424-1427.
[13]	ZHANG Xin-ge, MA Jie, WANG Qing-zhi, XIN Yue, YANG Chen-yan, XIONG Xi-wen. Gut epithelial Depdc5/mTORC1 signaling axis regulates mouse intestinal epithelial homeostasis [J]. Basic & Clinical Medicine, 2022, 42(8): 1213-1219.
[14]	LI Jie, PU Yang, ZHANG Meng-di, ZHANG Peng-ju, XU Yin-zhe. mTOR activation up-regulates MGST1 and enhances cellular antioxidant capacity [J]. Basic & Clinical Medicine, 2022, 42(4): 553-559.
[15]	LI Yong-xiao, SUN Yan, ZHANG Rui-sheng. Propofol inhibits proliferation of human endometrial cancer cell line RL95-2 [J]. Basic & Clinical Medicine, 2022, 42(1): 114-119.